• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON HUNGARY KFT (BD) BD ULTRASAFE PLUS¿ PASSIVE NEEDLE GUARD; ANTISTICK SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON HUNGARY KFT (BD) BD ULTRASAFE PLUS¿ PASSIVE NEEDLE GUARD; ANTISTICK SYRINGE Back to Search Results
Catalog Number 47451130
Device Problem Activation Problem (4042)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/21/2022
Event Type  malfunction  
Event Description
It was reported that the user could not activate the safety guard for the bd ultrasafe plus¿ passive needle guard.The following information was provided by the initial reporter: we had a needle that did not retract after release.Was someone (patient, health care worker, etc.) affected/harmed? if yes, please provide more information: death, no drug administration, serious public health threat, serious deterioration of health, delayed treatment ¿ no adrs reported with complaint.
 
Manufacturer Narrative
Date of event: unknown.The date received by manufacturer has been used for this field.Investigation summary: the customer issued a complaint for can¿t inject/activate problem detected by end user.No sample or photo was provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Based on the description bd assigned a quality criteria that is related to the reported condition and identified in the agreed specification.After reviewing the occurrence, irrespective of root cause, it is within the specification and no further action will be assigned.The report will not be updated if the sample is received after the approval of this report.The batch was manufactured and released according to applicable procedures and specifications.Consequently, bdm-ps will not define corrective or preventive actions following the investigation of this complaint.This complaint is registered in bd complaint system and trend analysis will be performed.Based on investigation conclusion, bdm-ps was not able to confirm the symptom perceived by customer or correlate this symptom with a potential cause linked to bd process.During the years of investigation of complaints about pre-activated devices several root causes were discovered which were within the customer¿s sphere of influence.H3 other text : see h10.
 
Manufacturer Narrative
H6: investigation summary: no sample or photo was provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Based on the description bd assigned a quality criteria that is related to the reported condition and identified in the agreed specification.After reviewing the occurrence, irrespective of root cause, it is within the specification and no further action will be assigned.The report will not be updated if the sample is received after the approval of this report.As this is a market event, the reported condition detected is not part of a sampling plan that allows to conclude about the whole batch, therefore the aql is not applicable.The batch was manufactured and released according to applicable procedures and specifications.Consequently, bdm-ps will not define corrective or preventive actions following the investigation of this complaint.This complaint is registered in bd complaint system and trend analysis will be performed.Based on investigation conclusion, bdm-ps was not able to confirm the symptom perceived by customer or correlate this symptom with a potential cause linked to bd process.
 
Event Description
It was reported that the user could not activate the safety guard for the bd ultrasafe plus¿ passive needle guard.The following information was provided by the initial reporter: we had a needle that did not retract after release.Was someone (patient, health care worker, etc.) affected/harmed? if yes, please provide more information: death, no drug administration, serious public health threat, serious deterioration of health, delayed treatment.No adrs reported with complaint.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ULTRASAFE PLUS¿ PASSIVE NEEDLE GUARD
Type of Device
ANTISTICK SYRINGE
Manufacturer (Section D)
BECTON DICKINSON HUNGARY KFT (BD)
uveggyar utca 3
kornye tatabanya 2851
HU  2851
Manufacturer (Section G)
BECTON DICKINSON HUNGARY KFT (BD)
uveggyar utca 3
kornye tatabanya 2851
HU   2851
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15620569
MDR Text Key307199439
Report Number3009081593-2022-00007
Device Sequence Number1
Product Code MEG
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K123743
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number47451130
Device Lot Number0247567
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-